23.11.2020 • News

Shell and Nexus in Pyrolysis-from-Waste Supply Deal

Shell and plastics recycling company Nexus Fuels have entered into a supply agreement for pyrolysis liquid made from plastic waste.

Nexus will supply 60,000 t of the liquid feedstock over four years from its plant in Atlanta, Georgia, USA.

Shell said the agreement follows a year of “continuous high-quality supply” to its chemical plant in Norco, Louisiana, where it has been used in the liquid cracker, and is a next step in its ambition to use 1 million t of plastic waste per year in its global chemical plants by 2025.

“Real-world, in-plant testing and application is key to proving technologies and scaling up production of chemicals from plastic waste. This new supply agreement with Nexus is built on that solid foundation and is a positive step towards providing our customers with bigger volumes of sustainable, circular chemicals,” said Thomas Casparie, executive vice president of Shell’s global chemicals business.

Nexus added that its fuels plant in Atlanta is the first multi-polymer pyrolysis operation in the US to receive ISCC Plus certification, which verifies product is sustainable, deforestation-free and traceable.

Author: Elaine Burridge, Freelance Journalist

Shell and plastics recycling company Nexus Fuels have entered into a supply...
Shell and plastics recycling company Nexus Fuels have entered into a supply agreement for pyrolysis liquid made from plastic waste. Nexus will supply 60,000 t of the liquid feedstock over four years from its plant in Atlanta, Georgia, USA. (c) Shell

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.